Compare Research And Ddevelopement To Revenue Across Equities
You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.
Cross Equities Research And Ddevelopement To Revenue Analysis
Compare Catalyst Pharmaceuticals, Kinetik Holdings, and Sellas Life Sciences Research And Ddevelopement To Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CPRX | 4.7177 | 39.8384 | 39.8384 | 39.8384 | 39.8384 | 39.8384 | 39.8384 | 39.8384 | 39.8384 | 0.1842 | 0.1385 | 0.1203 | 0.0924 | 0.2339 | 0.22 |
| KNTK | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| SLS | 7.1708 | 7.1708 | 7.1708 | 8.4745 | 3.0426 | 4.8853 | 4.8853 | 4.8853 | 4.8853 | 4.8853 | 4.8853 | 2.8124 | 30.268 | 27.24 | 28.6 |
| ENLT | 0.0613 | 0.0304 | 0.0091 | 6.0E-4 | 0.0103 | 0.0068 | 0.0068 | 0.0068 | 0.0068 | 0.0068 | 0.0396 | 0.0107 | 0.0291 | 0.0069 | 0.0065 |
| KEN | 0.0052 | 0.0052 | 0.0052 | 0.0052 | 0.0052 | 0.0052 | 0.0052 | 0.0052 | 0.0052 | 0.0052 | 0.0052 | 0.0032 | 0.0265 | 0.0226 | 0.0115 |
Catalyst Pharmaceuticals, Kinetik Holdings, and Sellas Life Sciences Research And Ddevelopement To Revenue description
The ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Baby Boomer Prospects Invested over 40 shares | |
 | Dividend Beast Invested over 50 shares | |
 | Power Assets Invested over 200 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Momentum Invested over 40 shares | |
 | Social Domain Invested few shares | |
 | Impulse Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Blockchain Invested few shares | |
 | Electronic Equipment Invested few shares | |
 | FinTech Invested few shares | |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance |